51 – 100 of 142
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Mortality and Inherited Thrombophilia: results from the European Prospective Cohort on Thrombophilia (EPCOT).
(
- Contribution to journal › Article
-
Mark
Origin of Swedish hemophilia A mutations
(
- Contribution to journal › Article
-
Mark
Exposure to factor VIII and prediction of inhibitor development: exposure days vs. danger days, or both?
(
- Contribution to journal › Letter
-
Mark
Demographic and clinical data in acquired hemophilia a: results from the european acquired haemophilia (each2) registry.
(
- Contribution to journal › Article
-
Mark
Influence of endothelial cell protein C receptor on plasma clearance of factor VIIa.
(
- Contribution to journal › Letter
-
Mark
Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa.
(
- Contribution to journal › Article
-
Mark
Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9-GP), a glycoPEGylated recombinant factor IX.
(
- Contribution to journal › Article
-
Mark
Family history of venous thromboembolism is associated with increased risk for thrombosis in multiple myeloma: a population-based study.
(
- Contribution to journal › Letter
- 2011
-
Mark
Parental history and venous thromboembolism: a nationwide study of age and sex-specific familial risks in Sweden.
(
- Contribution to journal › Article
-
Mark
Succinate independently stimulates full platelet activation via cAMP and PI3β kinase signaling.
(
- Contribution to journal › Article
-
Mark
Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following IV administration in haemophilia patients.
(
- Contribution to journal › Article
-
Mark
Induction of Auto-Antibodies Against β(2) -Glycoprotein I in Mice by Protein H of Streptococcus Pyogenes.
(
- Contribution to journal › Article
-
Mark
Wide temperature range testing with sonoclot plateletfunction and ROTEM EXTEM/FIBTEM/APTEM test
2011) International congress thrombosis hemostasis In Journal of Thrombosis and Haemostasis 9(s2). p.91-91(
- Contribution to journal › Published meeting abstract
-
Mark
Thirty-years' experience of prenatal diagnosis of haemophilia in Sweden
2011) XXIII Congress of the International Society on Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 9. p.462-462(
- Contribution to journal › Published meeting abstract
-
Mark
Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa).
(
- Contribution to journal › Article
-
Mark
Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays.
(
- Contribution to journal › Article
-
Mark
A Randomized Clinical Trial of Prophylaxis in Children with Hemophilia A (the ESPRIT Study).
(
- Contribution to journal › Article
- 2010
-
Mark
Gas6 is complexed to soluble tyrosine kinase receptor Axl in human blood.
(
- Contribution to journal › Article
-
Mark
Bio-distribution of pharmacologically administered recombinant factor VIIa (rFVIIa)
(
- Contribution to journal › Article
-
Mark
Novel APC-cleavage sites in FVa providing insights into mechanisms of action of APC and its cofactor protein S.
(
- Contribution to journal › Article
-
Mark
rFVIIa transported from the blood stream into tissues is functionally active
(
- Contribution to journal › Letter
-
Mark
APC-PCI complex as new tool for the evaluation of anticoagulant response to endogenous thrombin formation and its sequel in fibrinolysis
(
- Contribution to journal › Published meeting abstract
-
Mark
Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B
(
- Contribution to journal › Published meeting abstract
-
Mark
The role of phospholipid transfer protein in lipoprotein-mediated neutralization of the procoagulant effect of anionic liposomes.
(
- Contribution to journal › Article
-
Mark
Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol.
(
- Contribution to journal › Article
- 2009
-
Mark
Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A
(
- Contribution to journal › Article
-
Mark
Does an active sun exposure habit lower the risk of venous thrombotic events? A D-lightful hypothesis
(
- Contribution to journal › Article
-
Mark
The activation peptide of thrombin-activatable fibrinolysis inhibitor: a role in activity and stability of the enzyme?
(
- Contribution to journal › Article
-
Mark
Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A
(
- Contribution to journal › Article
-
Mark
Autologous plasma for the study of anaphylatoxinkinetics in man
2009) XXII Congress of the International Society of Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 7(s2).(
- Contribution to journal › Published meeting abstract
-
Mark
Prothrombin complex concentrate and effects on thecone and plate analyser
2009) XXII Congress of the International Society of Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 7(s2). p.885-885(
- Contribution to journal › Published meeting abstract
-
Mark
Comparison of two different heparin doses inperipheral vascular surgery
2009) XXII Congress of the International Society of Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 7(s2).(
- Contribution to journal › Published meeting abstract
-
Mark
Comparison of two infusionrates of antithrombinconcentrate in cardiopulmonary bypass surgery
2009) XXII Congress of the International Society of Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 7(s2). p.1075-1075(
- Contribution to journal › Published meeting abstract
-
Mark
Bedside point of care coagulation testing forindividualized antivitamin K reversal in emergencysurgery
2009) XXII Congress of the International Society of Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 7(s2). p.1167-1167(
- Contribution to journal › Published meeting abstract
-
Mark
Can proteins induced by vitamin K absence - PIVKA-II - detect subclinical vitamin k deficit in major surgery?
2009) International Congress on Thrombosis and Hemostasis, 2009 In Journal of Thrombosis and Haemostasis 7(s2). p.404-404(
- Contribution to journal › Published meeting abstract
-
Mark
An evaluation of monitoring possibilities of argatroban using rotational thromboelastometry and aPTT
2009) International Congress on Thrombosis and Hemostasis, 2009 In Journal of Thrombosis and Haemostasis 7(s2). p.871-872(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats
(
- Contribution to journal › Article
-
Mark
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)
(
- Contribution to journal › Article
- 2007
-
Mark
High incidence of concomitant venous thromboembolism in patients with portal vein thrombosis: a population study based on 23 796 consecutive autopsies
(
- Contribution to journal › Letter
-
Mark
Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A
(
- Contribution to journal › Article
-
Mark
Von Willebrand factor/factor VIII concentrate (Haemate(R) P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery.
(
- Contribution to journal › Article
-
Mark
Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin (R)): a prospective study of 50 patients
(
- Contribution to journal › Article
-
Mark
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)
(
- Contribution to journal › Article
-
Mark
An immunochemical method for quantitative determination of latent antithrombin, the reactive center loop-inserted uncleaved form of antithrombin.
(
- Contribution to journal › Article
-
Mark
Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice
(
- Contribution to journal › Article
- 2006
-
Mark
Are randomized clinical trials the only truth? Not always
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor
(
- Contribution to journal › Scientific review
-
Mark
The cleaved and latent forms of antithrombin are normal constituents of blood plasma: a quantitative method to measure cleaved antithrombin.
(
- Contribution to journal › Article
-
Mark
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)
(
- Contribution to journal › Article
-
Mark
Severity of acute coronary syndrome is predicted by interactions between fibrinogen concentrations and polymorphisms in the GPIIIa and FXIII genes
(
- Contribution to journal › Letter